← Back to Search

Apollo Wearable for Burnout

N/A

Recruiting

Led By Michelle Thompson, DO

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, on average 8 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial assesses how a wearable device (Apollo) can help reduce burnout in doctors by improving mood, energy, and focus.

Who is the study for?

This trial is for UPMC attending physicians and residents experiencing burnout. Participants must have an iOS or Android phone to join. Those who already own an Apollo device or are unwilling/unable to participate in the study cannot join.

What is being tested?

The study is testing the Apollo Wearable, a device that emits vibrations aimed at improving mood, energy, and focus. The goal is to see if it can help reduce feelings of burnout among physicians.

What are the potential side effects?

Since this trial involves a non-invasive wearable device emitting gentle vibrations, there may be minimal side effects such as discomfort from wearing the device or skin irritation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, on average 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, on average 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, on average 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Copenhagen Burnout Inventory

Perceived Stress Scale (PSS-10)

Secondary study objectives

Pittsburgh Sleep Quality Index (PSQI)

The Quick Inventory of Depressive Symptomatology

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Apollo Intervention ArmExperimental Treatment1 Intervention

Eligible UPMC Physicians and Residents who consent to be part of this study will use an Apollo Device TVS (10-200 Hz) attached to the subject's wrist or ankle via a commercially available wearable vibration technology that can deliver TVS (Transcutaneous Vibratory Stimulation). The intensity will be targeted for the sensory threshold (the level at which the vibration is just noticeable), as this is where the TVS seems most effective from prior studies. Similar vibratory stimuli have been demonstrated to be safe in the literature. The intensity of the vibration will be adjusted to the subjects' comfort and can be controlled by the subject at any time.

Do I qualify?Apply below to find out